Last reviewed · How we verify
Fitostimoline ® hydrogel group
Fitostimoline hydrogel promotes wound healing and tissue repair through stimulation of fibroblast activity and collagen synthesis.
Fitostimoline hydrogel promotes wound healing and tissue repair through stimulation of fibroblast activity and collagen synthesis. Used for Wound healing and tissue repair, Burn wounds, Surgical wounds.
At a glance
| Generic name | Fitostimoline ® hydrogel group |
|---|---|
| Sponsor | Federico II University |
| Drug class | Wound healing agent |
| Modality | Small molecule |
| Therapeutic area | Dermatology / Wound Care |
| Phase | FDA-approved |
Mechanism of action
Fitostimoline is a plant-derived polysaccharide complex that enhances the proliferative phase of wound healing by stimulating fibroblast function and promoting angiogenesis. The hydrogel formulation provides a moist wound environment while delivering the active compound to facilitate epithelialization and tissue regeneration.
Approved indications
- Wound healing and tissue repair
- Burn wounds
- Surgical wounds
- Chronic wounds
Common side effects
- Local irritation
- Allergic contact dermatitis
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fitostimoline ® hydrogel group CI brief — competitive landscape report
- Fitostimoline ® hydrogel group updates RSS · CI watch RSS
- Federico II University portfolio CI